Noveris Health Sciences is trading at CA$0.09, up 13.33%, after no September 22 company-specific catalyst was identified.
- The latest reported company news was September 9 annual and special meeting results.
- Broader markets were mixed, with the Nasdaq up 0.42%, providing limited support.
- The move may reflect low-priced-stock volatility or positioning; the catalyst remains unconfirmed.